H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis

Dirk Steffen Koschel, Martin Kolditz, Gert Hoeffken, Michael Halank

Med Sci Monit 2010; 16(5): CS55-57

ID: 878528

Available online: 2010-04-28

Published: 2010-04-28


Background: There are only a few reports of pulmonary hypertension (PH) in hypersensitivity pneumonitis (HP) and an approved vasomodulatory therapy for PH does not exist at all for interstitial lung disease (ILD), particularly for HP.
Material and Method: The case of a 53-year-old woman with chronic HP and severe life-threatening PH treated with a combined specific vasomodulatory therapy is reported. Sustained clinical and hemodynamic improvement was achieved.
Results:
Conclusions: Further investigation of PH in HP and specific vasomodulatory therapy is necessary.

Keywords: Sulfones - therapeutic use, Pyridazines - therapeutic use, Purines - therapeutic use, Piperazines - therapeutic use, Phenylpropionates - therapeutic use, Iloprost - therapeutic use, Hypertension, Pulmonary - drug therapy, Drug Therapy, Combination, Chronic Disease, Alveolitis, Extrinsic Allergic - complications, Vasodilator Agents - therapeutic use



Back